-
Workshop on “Knowledge on Artificial Intelligence applied to treatments decision-making”
As a member of the Horizon I3Lung project, Lung Cancer Europe (LuCE) will hold a workshop to explore the knowledge and trust on Artificial Intelligence…
-
8th LuCE Report – SURVEY: Financial impact of lung cancer. A European perspective.
8th LuCE Report – SURVEY: Financial impact of lung cancer. A European perspective: We are collecting data through an online survey, which objective is to explore…
-
A warm welcome to LuCE’s New Board
We wish to announce the newly elected LuCE Executive Board elected at the Annual General Meeting on 13 May 2023.
-
ERS International Congress 2023: Registration for patient representatives is now open.
The European Respiratory Society (ERS) International Congress 2023 will take place from 9–13 September 2023. It will be a hybrid conference, with the option to…
-
EPF Artificial Intelligence Survey
EPF began engaging in Artificial Intelligence (AI) in healthcare in 2020, from both a policy and capacity- building perspective.
-
Highlights of ELCC 2023
Lung Cancer Europe – Highlights of #ELCC2023
-
Incontinence and Mental Health: Call for Evidence on a Comprehensive Approach to Mental Health
In the 2022 State of the European Union address, European Commission President von den Leyen announced a new European Mental Health Strategy. As a result…
-
LuCE supports the WECAN statement concerning recent reports about the ECPC
LuCE is proud to support the WECAN statement concerning recent reports about the European Cancer Patient Coalition (ECPC) and the potential impact on EU research…
-
Project PEER: Understanding the lung cancer Patient Experience in the Real-world setting
Project PEER: Understanding the lung cancer Patient Experience in the Real-world setting